Search research articles
Contact Us
Filters
Showing results (231-240 of 750) with videos related to
Page
of 75
Sort By:
Alimentary Pharmacology & Therapeutics
|
May 17, 2024
Editorial: Has MetALD met the presumption? Authors' reply
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2024
Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
United European Gastroenterology Journal
|
March 12, 2025
Diagnosis and Monitoring Pathways Using Non-Invasive Tests in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease: Results From an Expert Delphi Panel
Virginia C Clark, Mark A Price, Jon Russo, et al.
Therapeutic Advances in Gastroenterology
|
May 23, 2022
Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis
Suzanne R Sharpton, Ondrej Podlaha, Jen-Chieh Chuang, et al.
Hepatology (Baltimore, Md.)
|
March 27, 2021
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 18, 2024
Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis
Kaleb Tesfai, Jordan Pace, Nora El-Newihi, et al.
Hepatology Communications
|
February 7, 2018
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
Zobair M Younossi, Maria Stepanova, Nila Rafiq, et al.
Alimentary Pharmacology & Therapeutics
|
May 20, 2020
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply
Rohit Loomba, Robert Wong, Jeremy Fraysse, et al.
Mayo Clinic Proceedings
|
June 14, 2021
Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2024
Editorial: Cardiometabolic criteria matters in MASLD-Authors' reply
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Page
of 75
Search research articles
Search
Showing results (231-240 of 750) with videos related to
Sort By:
Page
of 75
Alimentary Pharmacology & Therapeutics
|
May 17, 2024
Editorial: Has MetALD met the presumption? Authors' reply
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2024
Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
United European Gastroenterology Journal
|
March 12, 2025
Diagnosis and Monitoring Pathways Using Non-Invasive Tests in Patients With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease: Results From an Expert Delphi Panel
Virginia C Clark, Mark A Price, Jon Russo, et al.
Therapeutic Advances in Gastroenterology
|
May 23, 2022
Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis
Suzanne R Sharpton, Ondrej Podlaha, Jen-Chieh Chuang, et al.
Hepatology (Baltimore, Md.)
|
March 27, 2021
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 18, 2024
Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis
Kaleb Tesfai, Jordan Pace, Nora El-Newihi, et al.
Hepatology Communications
|
February 7, 2018
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
Zobair M Younossi, Maria Stepanova, Nila Rafiq, et al.
Alimentary Pharmacology & Therapeutics
|
May 20, 2020
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply
Rohit Loomba, Robert Wong, Jeremy Fraysse, et al.
Mayo Clinic Proceedings
|
June 14, 2021
Cost-Related Nonadherence to Medications Among US Adults With Chronic Liver Diseases
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, et al.
Alimentary Pharmacology & Therapeutics
|
September 3, 2024
Editorial: Cardiometabolic criteria matters in MASLD-Authors' reply
Nobuharu Tamaki, Takefumi Kimura, Shun-Ichi Wakabayashi, et al.
Page
of 75